REDWOOD CITY, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative ...

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Congenital Hyperinsulinism Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has ...

This page lists all known medications that could potentially lead to 'Hyperinsulinism' as a side effect. It's important to note that mild side effects are quite common with medications. The medication ...

REDWOOD CITY, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company developing a novel therapy to treat ...

Congenital hyperinsulinism is a genetic condition where a baby's pancreas secretes too much insulin. It affects approximately one in 50,000 live births and in severe cases requires the surgical ...

Congenital central hypoventilation syndrome (CCHS), a rare disorder typically presenting in the newborn period, results in over 90% of cases from PHOX2B polyalanine repeat mutations. It is ...

Researchers have discovered how a genetic mutation may lead to excess production of insulin, a condition known as congenital hyperinsulinism, even if the patients have not eaten any carbohydrates.

Please provide your email address to receive an email when new articles are posted on . Hyperinsulinemic hypoglycemia is the most dangerous form of hypoglycemia. Insulin affects not only glucose ...

Hyperinsulinism is the most common cause of persistent hypoglycemia in infants and children To date, mutations in five genes are known to encode proteins that cause congenital hyperinsulinism: ...

An investigational glucagon-like peptide-1 (GLP-1) antagonist, exendin-(9-39), prevents fasting and protein-induced hypoglycemia among children with congenital hyperinsulinism, new data suggest.

Diabetes is characterized by a deficiency of insulin. The opposite is the case in congenital hyperinsulinism: patients produce the hormone in excessive quantities. This leads to chronic hypoglycemia.